Whole genome analysis and gene expression profiling using peripheral blood cells to establish a new method for evaluation of medical diseases.

Cohort study to search for biomarkers that predict disease onset using human data, whole genome analysis, and gene expression profiling over 8 years of follow-up - Cohort study for biomarkers to predict disease onset

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051647

Enrollment

200

Registered

2023-07-19

Start date

2007-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes, hypertension, dyslipidemia, obesity, etc.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who received physical examination at Ishikawa Matto Central Hospital. Patients who underwent a 75 g oral glucose tolerance test (75 g OGTT) at 0 years and 8 years. patients with diabetes, hypertension, dyslipidemia, etc. Patients provided written informed consent before participation

Exclusion criteria

Exclusion criteria: Pregnant women.

Design outcomes

Primary

Measure	Time frame
Body composition, body weight, BMI, and blood pressure. HbA1c, laboratory evaluations, including hematology, serum chemistry, 75g OGTT. Gene expression profiling of peripheral blood cells. To analyze the association between gene excretion and biomarkers over an 8-year period.	—

Countries

Japan

Contacts

Public ContactToshinari Takamura

Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences Endocrinology & Metabolism

ttakamura@m-kanazawa.jp076-265-2234

Outcome results